Abstract. Cancer stem cells (CSCs) form spheres in vitro in serum-free suspension culture. Sphere formation is particularly useful to enrich the potential CSC subpopulations as a functional approach. Few reports are currently available on tumorspheres in esophageal cancer (EC). The present study focused on evaluating the cancer stem-like properties and analyzing the difference between spheroid and adherent cells of the Eca109 human EC cell line. Immunofluorescence and immunoblotting analysis revealed that EC tumorspheres expressed the stem cell markers Nanog and Oct4 more highly, but showed a decreased expression of the differentiation marker CK5/6. The spheroids were chemoresistant to cisplatin compared to the adherent cells (32.5 vs. 135.8 µM in IC 50 ). Side population cells increased in tumorspheres compared to adherent cells (0.7 vs. 5.6%). A marked upregulation of drug-resistant genes (ABCG2 and MDR1) was observed in sphere-forming cells. We compared the profiles of adherent and spheroid cells by microarrays and obtained one representative differentially expressed gene, aldehyde dehydrogenase (ALDH). We also verified that the cancer stem-like cells of EC contained a high ALDH enzymatic activity. ALDH-positive cells were enriched by 11-to 12-fold in spheroids, compared to adherent cells (2.5 vs. 28.6%). Immunofluorescence and immunoblotting analysis also revealed a higher expression of ALDH in EC tumorspheres. In conclusion, our study verified that sphere-forming culturing can be utilized to demonstrate the putative esophageal CSCs, and identified a potential esophageal CSC surface marker, ALDH.
Introduction
Esophageal cancer (EC) is a highly malignant neoplasm. The 5-year survival rate of patients is only 10% (1) . Advanced EC is one of the most refractory cancers and is associated with poor outcome. Conventional chemotherapy and radiotherapy are widely used for EC. However, more than 40% of EC cases eventually result in recurrence and patients succumb to chemotherapy-and radiotherapy-resistant disease (2) . Mounting evidence suggests that small populations of cells within tumors, known as cancer stem cells (CSCs), contribute to tumor maintenance and progression and are intrinsically resistant to therapies (3) . CSCs have the ability to recreate the full phenotypic heterogeneity of the parent tumor (4) . These cells express distinct surface markers allowing for reproducible and differential purification. Several stem cell markers, such as Nanog and Oct4, have been used successfully to identify CSCs in normal and tumor tissue (5) . In addition, side population (SP) cells found in various types of cancer have been reported to exhibit CSC characteristics (6) .
The anchorage-independent tumorsphere culture of stem cells was instrumental in the study of adult CSCs (7) (8) (9) . Sphere formation is particularly useful to enrich the potential CSC subpopulations as a functional approach (10, 11) . CSCs form spheres in vitro in serum-free suspension culture. In the suspension culture, tumorsphere-forming cells failed to express cytokeratins (CK), but were found to express stem cell markers (12) . Thus, the suspension culture system is thought to maintain CSCs in their undifferentiated state, facilitating their enrichment.
However, few reports are currently available regarding tumorspheres in EC. Therefore, the aim of the present study was to enrich and identify EC cell subsets with CSC properties. The tumorsphere of EC is considered to be a valuable model for the further study of both CSCs and chemoresistance. To select esophageal CSC markers, we performed comparative global gene expression analyses between adherent and spheroid cells. We compared profiles of adherent and spheroid cells and obtained one representative differentially expressed gene, aldehyde dehydrogenase (ALDH). We also verified that the cancer stem-like cells of EC contained a high ALDH enzymatic activity. Mouse anti-Nanog, Oct4, CK5/6 and ALDH1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were used as primary antibodies. Slides or spheroids were then washed with PBS for 15 min and secondary antibodies were incubated at 37˚C for 45 min. Alexa594-conjugated goat anti-mouse IgG (against anti-Nanog, Oct4 and CK5/6; Invitrogen) or FITC-conjugated goat anti-mouse IgG (against anti-ALDH1; Invitrogen) were used as secondary antibodies. The nuclei were stained with DAPI. Sections were examined with confocal microscopy (Olympus-FV1000, Japan).
Immunoblotting. Total protein was extracted from spheroid or adherent Eca109 cells using cell lysis buffer. Proteins were run in 10% SDS-PAGE and transferred on a PVDF sheet. The blots were incubated for 1-2 h in blocking solution (5% skimmed milk in Tris-buffer), and then for 1 h using the following primary antibodies: mouse anti-Nanog, Oct4, CK5/6, ABCG2, MDR1, ALDH1 and GAPDH (Santa Cruz). The sheet was then incubated for 1 h with HRP-conjugated secondary antibodies (Invitrogen) against mouse immunoglobulins. The bands were visualized using the ECL-Plus detection system (Bio-Rad, Hercules, CA, USA).
Drug sensitivity assay to antitumor drug. Cells obtained from adherent or spheroid Eca109 cells were seeded in 96-well microplates at a density of 3,000 cells/well. The cells were treated with increasing concentrations of cisplatin (Sigma-Aldrich, St. Louis, MO, USA) as indicated by the manufacturer's instructions. MTT assay was performed to determine the cell viability following exposure to cisplatin for 72 h. The number of living cells was directly proportional to the absorbance at 490 nm.
Hoechst staining and SP cell assay. Cells obtained from adherent or spheroid Eca109 cells were suspended in DMEM/2% FBS at 1x10 6 cells/ml and stained with Hoechst-33342 dye (5 µg/ml; Sigma-Aldrich) for 90 min at 37˚C. Following this incubation, cells were washed with ice-cold PBS and stained with propidium iodide (1 µg/ml; Sigma-Aldrich) to label and exclude dead cells. The cells were maintained at 4˚C for the flow cytometric analysis and for sorting of the SP fraction using a FACSAria flow cytometer (BD Biosciences, San Jose, CA, USA).
RNA isolation and microarray analysis. Eca109 spheroids were filtered by a cell strainer (40 µm; BD Biosciences). Spheroids with a diameter of >40 µm were selected. Total RNA was extracted separately from adherent and spheroid Eca109 cells using TRIzol reagent (Invitrogen), according to the manufacturer's instructions. RNA was subjected to GeneChip_ expression array analysis with two-cycle target labeling (implemented by CapitalBio Corp., Beijing, China). Briefly, cDNA was synthesized from total RNA using T7-Oligo (dT) primers, and biotinylated cRNA was synthesized using cDNA. Labeled cRNA (2 µg) was hybridized to the 22K Human Genome Array. The array image was scanned and analyzed using LuxScan 10KA.
Aldefluor assay by FACS. The ALDEFLUOR kit (StemCell Technologies, Durham, NC, USA) was used to analyze the population with a high ALDH enzymatic activity. Cells obtained from adherent or spheroid Eca109 cells were suspended in ALDEFLUOR assay buffer containing ALDH substrate and incubated during 40 min at 37˚C. As a negative control, for each sample of cells an aliquot was treated with 50 mmol/l diethylaminobenzaldehyde (DEAB), a specific ALDH inhibitor. FACS was performed using a FACSAria flow cytometer (BD Biosciences).
Statistical analyses. Data were analyzed using statistics soft SPSS 13.0 and were shown as the means ± SD. P<0.05 were considered statistically significant.
Results

Esophageal cancer tumorsphere contains cells with cancer stem-like properties.
Ponti et al first reported that breast CSC properties could be propagated in vitro as non-adherent mammospheres under serum-free culture conditions (13) . In the present study, we attempted to enrich the CSC population from the Eca109 EC cell line. To observe the differentiation of the tumorspheres, spheres were cultivated in serum-driven culture. After 48 h of culture, floating undifferentiated cells attached to the plastic, gradually migrating from tumorspheres and differentiating into adherent cells (Fig. 1A) . We detected two typical CSC markers, Nanog and Oct4, that were spheroid-cultured under differentiation conditions by immunofluorescence. In addition, the expression of the marker which indicates EC surface epithelium, CK5/6, was also observed. As shown in Fig. 1B , Nanog and Oct4 were expressed in the center of the semi-differentiated spheroids. However, a markedly decreased expression was observed at the edge of the semi-differentiated spheroids. Inversely, CK5/6 expression was almost absent in the center of the semi-differentiated spheroids, but was markedly expressed at the edge of the semi-differentiated spheroids.
Cancer stem-like properties were confirmed at the protein level in EC spheroids by immunoblotting. As expected, cancer cells cultured in the serum-free medium caused a CSC marker shift in the cells, including a marked upregulation of the CSC markers Nanog and Oct4, and the downregulation of the epithelium marker CK5/6 (Fig. 1C) . The results indicated that EC tumorspheres demonstrated an increased expression of stem cell markers.
EC tumorspheres exhibit an increased expression of ABC-transporter and resistance to chemotherapeutic drugs.
To examine whether EC tumorspheres possess a hypothesized chemoresistant phenotype of the CSCs, we assessed the sensitivity of the sphere-forming cells and the differentiated cells to drugs commonly used in chemotherapy. The EC tumor cells from the spheroids exhibited an increased IC 50 (half maximal inhibitory concentration) value (4-to 5-fold; 32.5 vs. 135.8 µM) to cisplatin compared to the control adherent cells (Fig. 2A) . Tumor cells resistant to chemotherapy occur in part due to the overexpression of ATP-binding cassette multidrug-resistance gene1 (MDR1) (14) and ATP-binding cassette sub-family G member 2 (ABCG2) (15) . This property correlates with the ability to expel dyes, defined as a flow cytometry SP (6) . SP cells have also been reported to exhibit CSC characteristics (16) . In our study, EC cells cultured in suspension cultures were found to contain an 8-fold increase in the proportion of SP Fig. 2B ). ABCG2 and MDR1 were also confirmed at the protein level by immunoblotting. The result indicated that ABCG2 and MDR1 were substantially increased in tumorspheres compared to the adherent cells (Fig. 2C) .
Gene expression profile analysis of EC spheroids based on microarray data. To clarify differential gene expression profiles between tumorsphere and the adherent cells of EC, microarray analysis was performed. A previous study has verified that the more serial passages in the spheroids, the more CSCs in spheroids (12) . To ensure the reliability of microarray results, we achieved the 20th passage of EC spheroids. The spheroids were filtered by a cell strainer. Spheroids with a diameter of >40 µm were selected to perform the microarray analysis (Fig. 3) . The mRNA expression profiles of the spheroid and adherent Eca109 cells were analyzed by human cDNA microarray. Among the 21,522 probes examined, 376 genes were upregulated (ratio >2.0) in the spheroid cells compared to the adherent cells, whereas 325 genes were downregulated in the spheroid cells. The upregulated genes were then assigned to a functional class using a gene ontology annotation tool by the Database for Annotation, Visualization and Integrated Discovery (Bioresource for array genes; http://david.abcc.ncifcrf.gov/). Based on their functions, the majority of these genes were classified into 'polymorphism', 'extracellular matrix', 'phosphoprotein', 'cell adhesion' and 'cell secretion' groups. In addition, we found 39 genes that showed a >5-fold upregulation in the spheroid cells compared to the adherent cells (Table I) . Among these genes, three upregulated genes of the ALDH family exhibited a >5-fold difference in expression, including ALDH1A1, ALDH1A3 and ALDH3A1 (Table I , bold).
EC spheroids contain high ALDH enzymatic activity. In the different profiles, we found that three ALDH family-related genes were significantly upregulated in the tumorsphere. ALDH, which detoxifies intracellular aldehydes through oxidation, may have a role in the differentiation of stem cells through the oxidation of retinoic acid. (17) ALDH expression has been suggested as a potential functional marker for CSCs (18) . To confirm this finding, we utilized the ALDEFLUOR assay to assess the size of the population with ALDH enzymatic activity in the Eca109 EC cell line. ALDEFLUORpositive cells were enriched by 11-to 12-fold in spheroids, compared to the adherent cells (2.5 vs. 28.6%; Fig. 4A ). The ALDH increase in the tumorsphere was further confirmed at the protein level by immunofluorescence and immunoblotting.
Immunofluorescence indicated that ALDH1 expression was observed in the tumorspheres, but was markedly decreased in the adherent cells (Fig. 4B) . Immunoblotting showed a similar result; ALDH1 was found to be upregulated in tumorspheres compared to the control adherent cells (Fig. 4C) . These results suggest that ALDH1-positive cells represent the stem/ progenitor population of EC.
Discussion
Current therapies for EC eliminate most cells within a tumor. However, advanced EC still progresses to incurable, androgenindependent metastatic disease (19) . According to the CSC hypothesis, current therapies fail to prevent cancer relapse and metastasis, since the small population of tumor stem cells is not susceptible to therapy (3). The tumorsphere, SP cells and drug-resistant cells have cancer stem-like properties. The SP technique is widely used to identify stem-like cells in cancer cells (20) . SP cells derived from primary EC cells were more resistant to chemotherapeutic reagents and formed more colonies in vitro than non-SP cells; xenograft experiments revealed that SP cells were more tumorigenic in vivo (21) . Drug resistance-related gene ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma (22) . Previous studies have reported the application of sphere culture to isolate, enrich, maintain or expand potential CSC subpopulations from various types of cancer (23) (24) (25) (26) (27) . It is generally agreed that, as with all stem cells, the tumorsphereforming cells are capable of proliferation and self-renewal and possess higher tumorigenicity. To the best of our knowledge, few reports are available on the propagation of esophageal CSCs using sphere culture. In the present study, we provide a systematic investigation of sphere-propagating cells that are derived from the Eca109 EC cell line.
The hypothesis that our tumorspheres exhibitied stem-like properties was based on the following observations: i) Nanog and Oct4 were expressed in the undifferentiated spheroid cells, but the expression of CK5/6 was markedly decreased in undifferentiated spheroid cells; ii) spheroid cells contain more Nanog and Oct4 protein, but less CK5/6 protein than adherent cells; iii) tumorspheres exhibited an increased resistance to cisplatin; iv) spheroid cells had an increased prevalence of SP cells and v) the ABC-transporter protein was enriched in spheroid cells compared to adherent cells. Therefore, we suggest that the non-adherent tumorspheres cultured in serum-free conditions possess esophageal CSC properties. Thus, suspension culture may effectively be used to enrich esophageal CSCs.
To understand the mechanisms underlying the difference in spheroid and adherent cells in the Eca109 cell line, we performed gene chip analysis and found that three genes from the ALDH family were highly expressed in esophageal cancer A B C stem-like cells. This observation was further confirmed by immunoblotting. ALDHs are a superfamily of 17 intra cellular enzymes that protect cells from the cytotoxic effects of peroxic aldehydes (28) . Increased ALDH activity has also been found in stem cell populations in various types of cancer (18) . ALDH activity may therefore provide a marker for normal and malignant stem as well as progenitor cells. Our study indicated that a high ALDH enzymatic activity is a function of EC tumorsphere. ALDH1 expression has been confirmed to associate with lymph node metastasis and poor survival in EC (29) . Thus, we believe that ALDH is a putative CSC marker of EC.
In conclusion, our study outlines a condition for long-term culture of EC stem-like cells. This system is likely to be beneficial for the investigation of unique properties of EC stem-like cells in terms of their biology and their specific cell surface marker expression that distinguishes them from common EC cells. Regarding specific surface markers that are associated with stem-like cells, our current understanding is that ALDH is a potential esophageal CSC surface marker. Nevertheless, esophageal CSC cell surface markers remain to be identified. EC tumorsphere and our tumorsphere microarray analysis data provide a unique opportunity to find and identify such markers.
